These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7921003)

  • 41. [Laboratory diagnosis of growth hormone].
    Macchia V; Mariano A
    Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):36-42. PubMed ID: 7910655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Paradoxical" growth hormone secretion in acromegaly: an avian model?
    Harvey S
    J Exp Zool Suppl; 1990; 4():195-9. PubMed ID: 1974792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
    Painson JC; Tannenbaum GS
    Endocrinology; 1991 Jun; 128(6):2858-66. PubMed ID: 1674685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6.
    Popovic V; Damjanovic S; Micic D; Petakov M; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1994 Aug; 79(2):456-60. PubMed ID: 8045963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can GHRH or GH secretagogues re-initiate pituitary GH pulsatility?
    Chappel S
    Clin Endocrinol (Oxf); 1999 May; 50(5):547-56. PubMed ID: 10468918
    [No Abstract]   [Full Text] [Related]  

  • 46. Letter: Growth hormone in acromegaly.
    Lancet; 1973 Oct; 2(7834):913. PubMed ID: 4126954
    [No Abstract]   [Full Text] [Related]  

  • 47. Growth hormone responses to the releasing hormones GHRH and GnRH and the inhibitors somatostatin and bromocriptine in TRH-responsive and non-responsive acromegalics.
    Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):53-8. PubMed ID: 2889308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
    Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hypothalamic mechanism in the pathogenesis of acromegaly].
    Giordano G; Marugo M; Minuto F; Barreca T
    Folia Endocrinol; 1974 Feb; 27(1):1-20. PubMed ID: 4619076
    [No Abstract]   [Full Text] [Related]  

  • 50. [Advances in endocrinology. Somatostatin. New hypothalamic hormone inhibiting the secretion of the growth hormone].
    Sliwowski A
    Pol Arch Med Wewn; 1975 Mar; 53(3):287-91. PubMed ID: 1089961
    [No Abstract]   [Full Text] [Related]  

  • 51. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
    Soya H; Suzuki M
    Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative study on the responses of plasma GH to synthetic GH-releasing factor and other stimulatory and inhibitory agents in patients with acromegaly.
    Hanew K; Sato S; Sasaki A; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1985 Feb; 145(2):161-6. PubMed ID: 2859672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of growth hormone secretion during normal conditions and in patients with acromegaly.
    Werner S
    Acta Endocrinol Suppl (Copenh); 1978; 216():179-86. PubMed ID: 274037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the mechanism of growth hormone autofeedback regulation: possible role of somatostatin and growth hormone-releasing factor.
    Conway S; McCann SM; Krulich L
    Endocrinology; 1985 Dec; 117(6):2284-92. PubMed ID: 2866085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Somatostatin inhibition of thyrotropin-releasing hormone- and growth hormone-releasing factor-induced growth hormone secretion in young and adult anesthetized chickens.
    Scanes CG; Harvey S
    Gen Comp Endocrinol; 1989 Aug; 75(2):256-64. PubMed ID: 2572506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonist.
    Jaffe CA; DeMott-Friberg R; Frohman LA; Barkan AL
    J Clin Endocrinol Metab; 1997 Feb; 82(2):634-7. PubMed ID: 9024267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cellular mechanism of growth hormone secretion by hypothalamic peptides].
    Kato M
    Nihon Ika Daigaku Zasshi; 1998 Oct; 65(5):402-4. PubMed ID: 9808996
    [No Abstract]   [Full Text] [Related]  

  • 58. Interplay of somatostatin and growth hormone-releasing hormone in genesis of episodic growth hormone secretion.
    Tannenbaum GS; Painson JC; Lapointe M; Gurd W; McCarthy GF
    Metabolism; 1990 Sep; 39(9 Suppl 2):35-9. PubMed ID: 1976217
    [No Abstract]   [Full Text] [Related]  

  • 59. Medical treatment of acromegaly.
    Goldfine ID
    Annu Rev Med; 1978; 29():407-15. PubMed ID: 25606
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of growth hormone (GH)-releasing hormone and somatostatin on leptin-induced GH secretion.
    Carro E; Señarís RM; Seoane LM; Frohman LA; Arimura A; Casanueva FF; Diéguez C
    Neuroendocrinology; 1999 Jan; 69(1):3-10. PubMed ID: 9892845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.